⌘K

Login Start Free

Home/Filings/4/0001104659-20-075234

4//SEC Filing

Erlander Mark 4

Accession 0001104659-20-075234

CIK 0001213037other

View on SEC.gov Company Profile

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 4:15 PM ET

Size

5.4 KB

Accession

0001104659-20-075234

Insider Transaction Report

Form 4

Period: 2020-06-17

Cardiff Oncology, Inc.CRDF

DirectorChief Executive Officer

Transactions

Award
Stock Options
2020-06-17+221,241→ 380,200 total
Exercise: $2.60Exp: 2030-06-17→ Common Stock (221,241 underlying)

Footnotes (1)

[F1]73,747 vest on each of 6/17/2021, 2022 and 2023.

Documents

1 file

4
a4.xmlPrimary
4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001651537

Filing Metadata

Form type: 4
Filed: Jun 18, 8:00 PM ET
Accepted: Jun 19, 4:15 PM ET
Size: 5.4 KB

View on SEC.gov